赛里斯治疗 (MCRB)
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, Davi
客服专线︰ +852 3018 4526
交易日︰全日24小时 | 非交易日：9:00-18:00
